KILITCH DRUGS Share Price

₹ 201.50

-₹4.22 (-2.05%)
1D
Last updated 03 Nov, 2026, 15:29 IST
NSE: KILITCH
|
Pharmaceuticals

KILITCH DRUGS Share Price Today

As of 3 Nov 2026, KILITCH DRUGS share price is ₹201.50. The stock opened at ₹205.07, compared to its previous close of ₹205.72. During today's trading session, KILITCH DRUGS share price moved in the range of ₹200.20 to ₹209.89, with an average price of ₹205.04 for the day. Looking at its last 52-week, the stock has touched a low of ₹117.25 and a high of ₹267.90. On the performance front, KILITCH DRUGS share price has increased by 33.57% over the last six months and is up 5.94% on a year-on-year basis.

Share price over the last 1 day fell from 203.33 to 201.50, ranging between 200.20 and 209.89.
₹200.20
2.05% down today
₹209.89
1D LOW
1D HIGH

KILITCH DRUGS Stock Insights

Latest Earning
Op Profit TrendUp by 12.13% YoY
Latest Earning
Net Profit TrendUp by 18.28% YoY
Latest Earning
Revenue TrendUp by 17.77% YoY
Stock Performance
OutperformingBeat Nifty by 13.35 % in last 3 month
Shareholding Pattern
DIIDII increased stake by 83050.00%
Shareholding Pattern
FIIFII decreased stake by 9.91%
KILITCH DRUGS stock performance
Open₹205.07
High₹209.89
Low₹200.20
Prev. close₹205.72
KILITCH DRUGS trading activity
Volume35,946
Average traded price₹205.32
Last traded time03:29:23 03 Nov
Last traded quantity47
Circuit
L
H
₹164.58
₹246.86
52-week
L
H
₹117.25
₹267.90
Mkt Cap Cr
702.73
P/E
24.71
P/B
2.58
ROA
6.38%
ROE
10.79%
ROCE
12.0%
Quick Ratio
1.73
EV/EBITDA
16.21

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Kilitch Drugs has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Kilitch Drugs appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Kilitch Drugs earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7390.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4826.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.132.566.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

KILITCH DRUGS Company Background

ISIN
INE729D01010
Sector Market Cap
₹ 702.73 Cr

Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is mainly engaged in the development and operations of the pharmaceutical business. Its services range from manufacturing to marketing a host of formulations in all dosage forms. The Company offers products in the categories of Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. It offers products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostics, uterine stimulants, veterinary and many more areas in the form of ampoules & vials. Its range of oral formulations includes tablets, capsules, dry syrups and oral powders. It provides a range of cosmetics ranging from oil, lotion, liquid to cream and paste in the skin care, personal care and hair care categories. It offers a medical device, namely, the C-Seal. ROIPAR, ROIVIT, PH-7, C-SEAL, SRO-KIT, 9-VIT, HPURE are their product offerings.

KILITCH DRUGS Financial Highlights

  • Revenue: KILITCH DRUGS reported revenue of ₹246.71 crore in FY26 vs ₹209.48 crore in FY25. It showed an increase of 17.77% on a yearly basis.
  • Operating Profit: KILITCH DRUGS reported an operating profit of ₹38.65 crore in FY26 vs ₹34.47 crore in FY25. It showed an increase of 12.13% on a year-on-year basis.
  • Net Profit: KILITCH DRUGS reported a net profit of ₹29.50 crore in FY26 vs ₹24.94 crore in FY25. It showed an increase of 18.28% on a yearly basis.

KILITCH DRUGS Quarterly Result Highlights

  • KILITCH DRUGS reported revenue of ₹47.78 crore in Jun 2026, compared with ₹90.09 crore in Mar 2026, representing a decrease of 46.96% on a quarter-on-quarter (QoQ) basis.
  • KILITCH DRUGS reported an operating profit of ₹3.86 crore in Jun 2026, compared with ₹20.21 crore in Mar 2026, representing a decrease of 80.90% on a quarter-on-quarter (QoQ) basis.
  • KILITCH DRUGS reported a profit of ₹1.97 crore in Jun 2026, compared with ₹14.88 crore in Mar 2026, reflecting a decrease of 86.76% on a QoQ basis.
  • The earnings per share (EPS) of KILITCH DRUGS stood at ₹8.91 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
63.77%
FII
0.11%
Other DII
0.50%
Retail and other
35.62%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.12%
Sep 20260.11%

KILITCH DRUGS Investment Returns

1 day
+2.19%
1 week
+3.24%
1 month
-5.85%
1 year
+5.94%
3 years
+35.23%
5 years
+144.03%

KILITCH DRUGS Share Price History

KILITCH DRUGS share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹201.81 / ₹205.72
+2.19%
30 Oct 26
₹211.45 / ₹201.32
-3.74%
29 Oct 26
₹210.20 / ₹209.14
-2.71%
28 Oct 26
₹206.50 / ₹214.97
+3.59%
Show more

KILITCH DRUGS Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹235.47₹198.32₹154.37₹139.60
Other Income₹11.24₹11.16₹4.48₹2.92
Total Revenue₹246.71₹209.48₹158.85₹142.52
Total Expenses₹208.06₹175.00₹139.50₹130.50
Profit Before Tax₹38.65₹34.47₹19.35₹12.01
Tax₹9.15₹9.53₹5.78₹3.73
Profit After Tax₹29.50₹24.94₹13.58₹8.28
EPS - Basic₹8.91₹16.60₹9.17₹6.71
EPS - Diluted₹8.91₹16.60₹9.17₹6.71

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹38.65₹34.47₹19.35₹12.01
Income before WC changes₹46.60₹35.64₹29.81₹21.80
Change in Assets-₹40.99-₹38.42-₹12.08-₹13.19
Change in Liabilities₹28.89₹28.80-₹12.23-₹1.70
Change in WC-₹12.11-₹9.63-₹24.31-₹14.88
Cash flow from Operations₹23.96₹17.54-₹1.53₹2.59
Cash flow from Investing-₹100.44-₹39.95-₹8.16₹7.92
Cash flow from Financing₹82.45₹13.24₹8.81-₹0.72
Total Cash Flow₹5.97-₹9.16-₹0.88₹9.78
Cash (Start of the year)₹9.80₹18.96₹19.85₹10.06
Cash (End of the year)₹15.77₹9.80₹18.96₹19.85

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹235.55₹138.87₹94.07₹93.12
Current Assets₹222.20₹173.92₹145.99₹126.40
Total Assets₹457.75₹312.78₹240.06₹219.52
Current Liabilities₹121.60₹84.31₹64.22₹68.87
Net Current Asset₹100.60₹89.61₹81.78₹57.53
Non-Current Liabilities₹59.28₹28.02₹0.17₹0.07
Equity Capital₹276.87₹200.46₹175.67₹150.58
Total Equity & Liabilities₹457.75₹312.78₹240.06₹219.52

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹188.57₹181.59₹131.60₹117.78
Other Income₹13.85₹13.72₹6.19₹4.60
Total Revenue₹202.42₹195.30₹137.79₹122.38
Total Expenses₹160.87₹154.61₹114.43₹102.93
Profit Before Tax₹41.55₹40.69₹23.35₹19.45
Tax₹9.15₹9.53₹5.78₹3.73
Profit After Tax₹32.40₹31.16₹17.57₹15.72
EPS - Basic₹9.57₹19.37₹11.03₹10.09
EPS - Diluted₹9.57₹19.37₹11.03₹10.09

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹41.55₹40.69₹23.35₹19.45
Income before WC changes₹42.44₹35.00₹25.22₹21.40
Change in Assets-₹41.14-₹32.83-₹18.15-₹12.35
Change in Liabilities₹21.56₹21.53-₹2.61₹1.37
Change in WC-₹19.58-₹11.30-₹20.76-₹10.97
Cash flow from Operations₹12.32₹15.23-₹2.58₹6.10
Cash flow from Investing-₹96.00-₹41.42-₹8.71₹6.24
Cash flow from Financing₹85.57₹15.65₹11.40₹3.04
Total Cash Flow₹1.89-₹10.54₹0.11₹15.39
Cash (Start of the year)₹7.41₹17.95₹17.84₹2.45
Cash (End of the year)₹9.30₹7.41₹17.95₹17.84

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹293.31₹195.78₹145.98₹137.65
Current Assets₹206.14₹162.38₹141.49₹114.77
Total Assets₹499.46₹358.16₹287.47₹252.42
Current Liabilities₹107.17₹77.20₹64.37₹56.42
Net Current Asset₹98.98₹85.18₹77.11₹58.35
Non-Current Liabilities₹59.28₹28.02₹0.17₹0.07
Equity Capital₹333.01₹252.94₹222.92₹195.93
Total Equity & Liabilities₹499.46₹358.16₹287.47₹252.42
* All values are in INR Crore
KILITCH DRUGS market depth
Bid quantityBid priceAsk priceAsk quantity
00202.13122
0000
0000
0000
0000
Total bid quantity0
Total ask quantity122
KILITCH DRUGS technical summary
Bearish indicators2
Neutral indicators5
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
45.55
Neutral
ATR (14)
14.69
Neutral
STOCH(9,6)
34.73
Neutral
STOCH RSI (14)
26.97
Neutral
ADX(9)
24.42
Bearish
UO(9)
37.29
Neutral
ROC(12)
-10.7
Bearish
WillR(14)
-80.12
Bullish
Period
Simple value
Exponential vaue
5D
207.74
206.41
10D
206.5
209.87
20D
223.65
213.41
50D
203.11
207.09
100D
194.1
196.02
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

KILITCH DRUGS
Pharmaceuticals
Add Stock
Add Another

KILITCH DRUGS Returns Calculator

Ex-date: 24 Mar 2026

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

KILITCH DRUGS Share Price FAQs

Please be aware that KILITCH DRUGS stock prices are subject to continuous fluctuations due to various factors.